Boundless Bio, founded in 2018, is a biopharmaceutical company that develops novel cancer therapeutics seeking to understand and treat intractable cancers. Boundless Bio aims to interrogate extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers. Boundless Bio is headquartered in La Jolla, California.

Register for Details

For more details on financing and valuation for Boundless Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Boundless Bio

Forge green plus iconForge green minus icon

What is Boundless Bio's funding to date?

Boundless Bio has raised $252.05MM to date.
Forge green plus iconForge green minus icon

When was Boundless Bio founded?

Boundless Bio was founded in 2018.

Who are Boundless Bio's major investors?

Wellington Management
Ra Capital Management
Arch Venture Partners
Fidelity Management & Research
Redmile Group
Logos Capital
Cambridge Innovation Capital
Leaps by Bayer
Sectoral Asset Management
HealthCap
Boxer Capital
Nextech Invest
National Cancer Institute
Surveyor Capital
Vertex Ventures HC
City Hill Ventures
Tavistock Group
PFM Health Sciences
GT Healthcare Capital Partners
Citadel Enterprise Americas

Boundless Bio Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
5/16/2023 Series C $100MM raised $XXX.XX $XXX.XX
4/28/2021 Series B $105.59MM raised $XXX.XX $XXX.XX
9/19/2019 Series A $46.47MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Nov 15, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.